Johnson & Johnson 2022: Driving change, collaboration, and innovation Issue Archives, October 2022, Therapeutics 2022 has been marked by the first year of leadership under CEO Joaquin Duato and the anticipated separation of the company’s consumer health business. Read more October 11, 2022/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2022/10/Joaquin-Duato.jpeg 508 600 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2022-10-11 03:15:112022-10-04 11:41:39Johnson & Johnson 2022: Driving change, collaboration, and innovation
